Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides

Peptides

Volumn 20, Issue 4, 1999, Pages 493-500

  Paula, Renata D ^a   Lima, Celso V ^a   Britto, Raquel R ^a   Campagnole Santos, Maria J ^a   Khosla, Mahesh C ^a   Santos, Robson A S ^a  

^a Depto Fisiol Biofis Inst Cie B   (Brazil)

Author keywords

A 779; Angiotensin (1 5); Angiotensin (1 6); Angiotensin (1 7); Angiotensin (2 7); Angiotensin (3 7); Angiotensin (4 7); Angiotensins; Blood vessels; Converting enzyme inhibitors; Endothelial cells; Kinins

Indexed keywords

ANGIOTENSIN DERIVATIVE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FLUOROMETRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRADYKININ; DRUG SYNERGISM; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; WAKEFULNESS;

RATTUS NORVEGICUS;

EID: 0032887754     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00031-5     Document Type: Article

References (43)

1. Abbas A., Gorelik G., Carbini L.A., Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 30:(Part 1):1997;217-221.
2. Abhold R.H., Harding J.W. Metabolism of angiotensin II and angiotensin III by membrane bounded peptidases from rat brain. J Pharmacol Exp Ther. 245:1988;171-177.
3. Benter I.F., Diz D.I., Ferrario C.M. Cardiovascular actions of angiotensin-(1-7). Peptides. 14:(4):1993;679-684.
4. Braszko J.J., Wlasienko J., Koziolkiewicz W., Janecka A., Wisniewski K. The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res. 542:1991;49-54.
5. Brosnihan K.B., Li P., Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 27:1996;523-528.
6. Campagnole-Santos M.J., Heringer S.B., Batista E.N., Khosla M.C., Santos R.A.S. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol. 263:(1):1992;R89-R94.
7. Campbell D.J., Kladis A., Duncan A. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 22:1993;513-522.
8. Chappell M.C., Piro N.T., Sykes A., Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 31:(Part 2):1998;362-367.
9. Chappell M.C., Tallant E.A., Brosnihan K.B., Ferrario C.M. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol. 5:1994;129-137.
10. Deddish P.A., Marcic B., Jackman H.L., Wang H.Z., Skidgel A.R., Erdos E.G. N-Domain-specific substrate and c-domain inhibitors of angiotensin-converting enzyme angiotensin-(1-7) and keto-ACE . Hypertension. 31:1998;912-917.
11. Erdös E.G., Skidgel R.A. Renal metabolism of angiotensin I and II. Kidney Int. 38:1990;24-27.
12. Fagundes-Moura CR. Perfil plasmático de angiotensinas durante o desenvolvimento da hipertensão renal tipo 1 rim, 1 clip em ratos. Efeito do Tratamento com Losartan. Thesis, Universidade Federal de Minas Gerais; 1997.
13. Ferrario C.M., Chappell M.C., Tallant E.A., Brosnihan K.B., Diz D.I. Counterregulatory actions of angiotensin-(1-7). Hypertension. 30:(Part 2):1997;535-541.
14. Ferreira S.H. A bradykinin-potentiating factor (BPF) in the venom of Bothrops jararaca. Br J Pharmacol Chemother. 24:1965;163-169.
15. Freeman E.J., Chisolm G.M., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 28:1996;104-108.
16. 3H]norepinephrine from rat atria. Hypertension. 24:1994;457-460.
17. Greene L.J., Spadaro A.C., Martins A.R., Perussi de Jesus W.D., Camargo A.C.M. Brain endo-oligopeptidase B a post-proline cleaving enzyme that inactivates angiotensin I and II . Hypertension. 4:1982;178-184.
18. Hecker M., Blaukat A., Bara A.T., Müller-Esterl W., Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br J Pharmacol. 121:1997;1475-1481.
19. Iyer S.N., Ferrario C.M. Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 31:(Part 2):1998;356-361.
20. Jaiswal N., Diz D.I., Chappell M.C., Khosla M.C., Ferrario C.M. Stimulation of endothelial cell prostaglandin production by angiotensin peptides characterization of receptors . Hypertension. 19:(Suppl. II):1992;II-49-II-55.
21. Johnson A.R., Erdös E.G. Metabolism of vasoactive peptides by human endothelial cells in culture angiotensin I converting enzyme (kininase II) and angiotensinase . J Clin Invest. 59:1977;684-695.
22. Kohara K., Brosnihan K.B., Ferrario C.M. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides. 14:1993;883-891.
23. Kono T., Taniguchi A., Imura H., Oseko F., Khosla M.C. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci. 38:(16):1986;1515-1519.
24. Li P., Chappell M.C., Ferrario C.M., Brosnihan K.B. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 29:(Part 2):1997;394-400.
25. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., Santos R.A.S. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension. 30:(Part 2):1997;542-548.
26. 2 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res. 81:1997;848-856.
27. Neuβb M., Regitz-Zagrosck V., Hildebrandt A., Fleck E. Human cardiac fibroblasts express an angiotensin receptor unusual binding characteristics, that is coupled proliferation. Biochem Biophys Res Commun. 204:(3):1994;1334-1339.
28. Neves L.A.A., Almeida A.P., Khosla M.C., Santos R.A.S. Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors. Biochem Pharmacol. 50:(9):1995;1451-1459.
29. Neves L.A.A., Almeida A.P., Khosla M.C., Campagnole-Santos M.J., Santos R.A.S. Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res. 30:(6):1997;801-809.
30. Osei S.Y., Ahima R.S., Minkes R.K., Weaver J.P., Khosla M.C., Kadowitz P.J. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. J Pharmacol. 234:1993;35-42.
31. Paula R.D., Lima C.V., Khosla M.C., Santos R.A.S. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 26:(Part 2):1995;1154-1159.
32. Paula R.D., Lima C.V., Khosla M.C., Santos R.A.S. Papel do óxido nítrico na potenciação do efeito hipotensor da bradicinina pela angiotensina-(1-7). (abstract). X Reunião Annual da Federação de Sociedade de Biologia Experimental. 1:1995;131.
33. Salgado M.C.O., Krieger E.M. Acute changes in the renin-angiotensin system modify bradykinin and metabolism in conscious rats. Hypertension. 5:(Suppl. V):1983;V-172-V-6.
34. Santos R.A.S., Brosnihan K.B., Chappell M.C., Pesquero J.L., Chernicky C.L., Greene L.J., Ferrario C.M. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension. 11:1988;153-157.
35. Santos R.A.S., Brosnihan K.B., Jacobsen D.W., DiCorleto P.E., Ferrario C.M. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension. 19:(Suppl. II):1992;II-56-II-61.
36. Santos R.A.S., Brum J.M., Brosnihan K.B., Ferrario C.M. The renin-angiotensin system during acute myocardial ischemia in dogs. Hypertension. 15:(Suppl. I):1990;I-121-I-7.
37. Santos R.A.S., Campagnole-Santos M.J. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res. 27:1994;1033-1047.
38. Santos R.A.S., Campagnole-Santos M.J., Baracho N.C.V., Fontes M.A.P., Silva L.C.S., Neves L.A.A., Oliveira D.R., Caligiorne S.M., Rodrigues A.R.V., Gropen C. Jr, Carvalho W.S., Simões e Silva A.C., Khosla M.C. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7) evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors . Brain Res Bull. 35:1994;239-298.
39. Santos R.A.S., Krieger E.M., Greene L.J. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension. 7:1985;244-252.
40. Tallant E.A., Lu X., Weiss R.B., Chappell M.C., Ferrario C.M. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 29:(Part 2):1997;338-393.
41. Tan F., Morris P.W., Skidgel R.A., Erdös E.G. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C) similarity to both serine carboxypeptidase and prolylendopeptidase families . J Biol Chem. 268:1993;16631-16638.
42. Tran Y., Forster C. Angiotensin-(1-7) and the rat aorta: modulation by endothelium. J Cardiovasc Pharmacol. 30(5:1997;676-682.
43. Yamamoto K., Chappell M.C., Brosnihan B., Ferrario C.M. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. 19:1992;692-696.